• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by CorVel Corp.

    11/6/25 4:56:26 PM ET
    $CRVL
    Specialty Insurers
    Finance
    Get the next $CRVL alert in real time by email
    S-8 1 d82229ds8.htm S-8 S-8

    As Filed With the Securities and Exchange Commission on November 6, 2025

    Registration No. 333-   

     

     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM S-8

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

    CORVEL CORPORATION

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   33-0282651

    (State or other jurisdiction of

    incorporation or organization)

     

    (I.R.S. Employer

    Identification No.)

    5128 Apache Plume Road, Suite 400

    Fort Worth, Texas 76109

    (Address of principal executive offices and zip code)

    CorVel Corporation 2025 Stock Incentive Plan

    (Full title of the plan)

    Michael G. Combs

    5128 Apache Plume Road, Suite 400

    Fort Worth, Texas 76109

    (949) 851-1473

    (Name, address and telephone number, including area code, of agent for service)

    Copies to:

    Ryan C. Wilkins, Esq.

    Stradling Yocca Carlson & Rauth LLP

    660 Newport Center Drive, Suite 1600

    Newport Beach, California 92660

    (949) 725-4000

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer   ☒    Accelerated filer   ☐
    Non-accelerated filer   ☐    Smaller reporting company   ☐
         Emerging growth company   ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     
     


    EXPLANATORY NOTE

    This Registration Statement on Form S-8 (this “Registration Statement”) is being filed by CorVel Corporation, a Delaware corporation (the “Registrant”), to register 1,775,459 shares of the Registrant’s common stock, par value $0.0001 per share (the “Common Stock”), to be issued under the CorVel Corporation 2025 Stock Incentive Plan (the “2025 Plan”), which was approved by the Registrant’s stockholders on August 7, 2025.


    PART I

    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

    The information specified in Item 1 and Item 2 of Part I of Form S-8 is omitted from this Registration Statement in accordance with Rule 428 under the Securities Act of 1933, as amended (the “Securities Act”), and the introductory note to Part I of Form S-8. The documents containing the information specified in Part I of Form S-8 will be delivered to the participants in the 2025 Plan as specified by Rule 428(b)(1) under the Securities Act.


    PART II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 3.

    Incorporation of Documents by Reference.

    The following documents, which have been filed by the Registrant with the Commission, are hereby incorporated by reference herein, and shall be deemed to be a part of, this Registration Statement:

     

      •  

    the Registrant’s Annual Report on Form 10-K for the fiscal year ended March 31, 2025, filed with the Commission on May  23, 2025 (the “Annual Report”), including the Description of Securities set forth in Exhibit 4.1 attached thereto, as well as any amendments to such exhibit filed for the purpose of updating such description;

     

      •  

    the information specifically incorporated by reference into the Registrant’s Annual Report on Form 10-K from the Registrant’s Definitive Proxy Statement on Schedule  14A filed with the SEC on June 24, 2025;

     

      •  

    the Registrant’s Quarterly Reports on Form 10-Q for the fiscal quarters ended June 30, 2025, filed with the Commission on August 7, 2025, and September 30, 2025, filed with the Commission on November 6, 2025; and

     

      •  

    the Registrant’s Current Reports on Form 8-K, filed with the Commission on August  13, 2025 and September 12, 2025.

    All documents filed by the Registrant pursuant to Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered have been sold, or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part of it from the respective dates of filing such documents; except as to any portion of any future annual, quarterly or current report or other document, or any portion thereof, that is deemed furnished and not deemed filed under such provisions. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for the purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document, which also is or is deemed to be incorporated by reference herein, modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

     

    Item 4.

    Description of Securities.

    Not applicable.

     

    Item 5.

    Interests of Named Experts and Counsel.

    Not applicable.

     

    Item 6.

    Indemnification of Directors and Officers.

    The following summary is qualified in its entirety by reference to the Delaware General Corporation Law (the “DGCL”), the Registrant’s Fourth Amended and Restated Certificate of Incorporation, as amended (the “Charter”), and the Registrant’s Second Amended and Restated Bylaws (the “Bylaws”).

    Section 102(b)(7) of the DGCL provides that a corporation may in its certificate of incorporation eliminate or limit the personal liability of a director or officer to the corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director or officer, except for liability: (i) for any breach of the director’s or officer’s duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve


    intentional misconduct or a knowing violation of law, (iii) under Section 174 of the DGCL (pertaining to certain prohibited acts including unlawful payment of dividends or unlawful purchase or redemption of the corporation’s capital stock, or (iv) for any transaction from which the director or officer derived an improper personal benefit. The Charter provides that to the fullest extent permitted by the DGCL, no director of the Registrant shall be personally liable to the Registrant or its stockholders for monetary damages for any breach of fiduciary duty as a director.

    Section 145(a) of the DGCL provides, in relevant part, that a corporation may indemnify any person who was or is a party, or is threatened to be made a party, to any threatened, pending or completed action, suit or proceeding (other than an action by or in the right of the corporation) by reason of the fact that such person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, including against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person’s conduct was unlawful.

    Section 145(b) of the DGCL provides, in relevant part, that a corporation may indemnify any person who was or is a party, or is threatened to be made a party, to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that such person acted in any of the capacities set forth above, including against expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit if such person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Delaware Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Delaware Court of Chancery or such other court shall deem proper.

    Section 145 of the DGCL further provides that, to the extent a director or officer of a corporation has been successful on the merits or otherwise in the defense of any action, suit or proceeding referred to in Section 145(a) and (b), or in defense of any claim, issue or matter therein, such person shall be indemnified, including against expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection therewith; that indemnification provided for by Section 145 shall not be deemed exclusive of any other rights to which the indemnified party may be entitled; and the indemnification provided for by Section 145 shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of such person’s heirs, executors and administrators. Section 145 also empowers the corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of his status as such, whether or not the corporation would have the power to indemnify such person against such liabilities under Section 145.

    The Bylaws provide that the Registrant shall, to the fullest extent permitted by Section 145 of the DGCL, indemnify any director or officer of the Registrant against expenses (including attorneys’ fees), judgements, fines, amounts paid in settlement, and/or other matters referred to in or covered by Section 145 of the DGCL, by reason of the fact that such individual is or was a director, officer, employee or agent of the Registrant, or is or was serving at the request of the Registrant as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise; and that the Registrant shall also pay expenses incurred in defending any such proceeding in advance of its final disposition upon delivery of an undertaking, by or on behalf of an indemnified person, to repay all amounts so advanced if it should be determined ultimately that such person is not entitled to be indemnified under the DGCL or otherwise.

    The Registrant provides liability insurance for its directors and officers which provides for coverage against loss from claims made against directors and officers in their capacity as such, including liabilities under the Securities Act.


    Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that, in the opinion of the Commission, such indemnification is against public policy and is, therefore, unenforceable.

     

    Item 7.

    Exemption from Registration Claimed.

    Not applicable.

     

    Item 8.

    Exhibits.

     

    Exhibit
    Number
      

    Description

      

    Registrant’s

    Form

      

    Filing

    Date

      

    Exhibit

    Number

    3.1†    Fourth Amended and Restated Certificate of Incorporation of CorVel Corporation    10-Q    8/6/2020    3.1
    3.2†    Certificate of Amendment of Fourth Amended and Restated Certificate of Incorporation of CorVel Corporation    8-K    12/26/2024    3.1
    3.3†    Second Amended and Restated Bylaws of CorVel Corporation    10-Q    8/6/2020    3.2
    5.1*    Opinion of Stradling Yocca Carlson & Rauth LLP         
    10.1†    CorVel Corporation 2025 Stock Incentive Plan    DEF 14A    6/24/2025    Appendix A
    10.2*    Notice of Stock Option Grant and Stock Option Agreement         
    23.1*    Consent of Independent Registered Public Accounting Firm         
    23.2*    Consent of Stradling Yocca Carlson & Rauth LLP (included in Exhibit 5.1 hereto)         
    24.1*    Power of Attorney (included on signature page hereto)         
    107*    Filing Fee Table         

     

    †

    Filed as an exhibit to the referenced form and incorporated by reference herein.

    *

    Filed herewith.

     

    Item 9.

    Undertakings.

     

    (a)

    The undersigned Registrant hereby undertakes:

     

      (1)

    To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

     

      (i)

    To include any prospectus required by Section 10(a)(3) of the Securities Act;

     

      (ii)

    To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in Exhibit 107 (Filing Fee Table) to the effective Registration Statement; and


      (iii)

    To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;

    Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the Registration Statement is on Form S-8, and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.

     

     

      (2)

    That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

      (3)

    To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     

    (b)

    The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act), that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    (c)

    Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.


    SIGNATURES

    Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Irvine, California, on November 6, 2025.

     

    CORVEL CORPORATION
    By:  

    /s/ Michael G. Combs

      Michael G. Combs
     

    Chairman of the Board, Chief Executive Officer and President

    (Principal Executive Officer)

    POWER OF ATTORNEY

    KNOW ALL PERSONS BY THESE PRESENTS that each individual whose signature appears below constitutes and appoints Michael G. Combs and Brian S. Nichols, and each of them individually, his or her true and lawful attorney-in-fact and agent, with full power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or his, her or their substitute or substitutes, may lawfully do or cause to be done or by virtue hereof.

    Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

     

    Signature

      

    Title

      

    Date

    /s/ Michael G. Combs

       Chairman of the Board, Chief Executive Officer and President    November 6, 2025
    Michael G. Combs    (Principal Executive Officer)   

    /s/ Brian S. Nichols

       Chief Financial Officer    November 6, 2025
    Brian S. Nichols    (Principal Financial Officer)   

    /s/ Jennifer L. Yoss

       Vice President, Accounting    November 6, 2025
    Jennifer L. Yoss    (Principal Accounting Officer)   

    /s/ Joanna C. Burkey

       Director    November 6, 2025
    Joanna C. Burkey      

    /s/ Steven J. Hamerslag

       Director    November 6, 2025
    Steven J. Hamerslag      

    /s/ Alan R. Hoops

       Director    November 6, 2025
    Alan R. Hoops      

    /s/ R. Judd Jessup

       Director    November 6, 2025
    R. Judd Jessup      

    /s/ Jeffrey J. Michael

       Director    November 6, 2025
    Jeffrey J. Michael      
    Get the next $CRVL alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CRVL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CRVL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CorVel Announces Revenues and Earnings

    FORT WORTH, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter ended September 30, 2025. Revenues for the quarter were $240 million, an increase from $224 million in the September quarter of 2024. Earnings per share for the quarter were $0.54, compared to $0.45 in the same quarter of the prior year. Revenues for the six months ended September 30, 2025 were $474 million, an increase from $436 million during the six months ended September 30, 2024. Earnings per share for the six months ended September 30, 2025 were $1.06, compared to $0.87 during the six months ended September 30, 2024. The earnings per share numbers for the curren

    11/4/25 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Corporation to Host Live Earnings Release Webcast

    FORT WORTH, Texas, Oct. 21, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Tuesday, November 4, 2025, at 11:30 AM Eastern Time. During the webcast, CorVel will also introduce its newly appointed Chief Financial Officer, Brian Nichols. The webcast will feature a discussion of CorVel's financial performance, strategic initiatives, and outlook, led by Michael Combs, President and Chief Executive Officer, alongside Brian Nichols. The event will also include a dedicated question-and-answer session for attendees. W

    10/21/25 9:13:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    Three CorVel Partners Recognized as 2025 Theo Award Winners for Excellence in Workers' Compensation

    FORT WORTH, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Today, CorVel Corporation (NASDAQ:CRVL), a national provider of risk management solutions, is proud to announce that Sharp HealthCare, the State of North Carolina, and The Save Mart Companies have been recognized as winners in the 2025 Theo Awards. These CorVel partners were recognized for their outstanding achievements in workers' compensation through their innovation and measurable results in addressing complex industry challenges. The annual Theo Awards highlight organizations that have transformed their approach to workplace safety, claims management, and employee care. This year's CorVel partners successfully addressed industry-sp

    9/10/25 7:22:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $CRVL
    SEC Filings

    View All

    Vice President of Accounting Yoss Jennifer was granted 35 shares, increasing direct ownership by 2% to 2,123 units (SEC Form 4)

    4 - CORVEL CORP (0000874866) (Issuer)

    10/1/25 4:44:52 PM ET
    $CRVL
    Specialty Insurers
    Finance

    CEO & President Combs Michael G was granted 44 shares, increasing direct ownership by 0.10% to 44,325 units (SEC Form 4)

    4 - CORVEL CORP (0000874866) (Issuer)

    10/1/25 3:59:17 PM ET
    $CRVL
    Specialty Insurers
    Finance

    EVP - Risk Management Services Bertels Mark E. was granted 8 shares, increasing direct ownership by 0.31% to 2,594 units (SEC Form 4)

    4 - CORVEL CORP (0000874866) (Issuer)

    10/1/25 3:36:29 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form S-8 filed by CorVel Corp.

    S-8 - CORVEL CORP (0000874866) (Filer)

    11/6/25 4:56:26 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form 10-Q filed by CorVel Corp.

    10-Q - CORVEL CORP (0000874866) (Filer)

    11/6/25 4:30:50 PM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CORVEL CORP (0000874866) (Filer)

    11/3/25 7:30:26 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Leadership Updates

    Live Leadership Updates

    View All

    CorVel Corporation to Host Live Earnings Release Webcast

    FORT WORTH, Texas, Oct. 21, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Tuesday, November 4, 2025, at 11:30 AM Eastern Time. During the webcast, CorVel will also introduce its newly appointed Chief Financial Officer, Brian Nichols. The webcast will feature a discussion of CorVel's financial performance, strategic initiatives, and outlook, led by Michael Combs, President and Chief Executive Officer, alongside Brian Nichols. The event will also include a dedicated question-and-answer session for attendees. W

    10/21/25 9:13:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Corporation Appoints Sarah Scott as Executive Vice President of Product

    FORT WORTH, Texas, Feb. 13, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDQ: CRVL), a national provider of risk management solutions, today announced the promotion of Sarah Scott to Executive Vice President of Product. In her expanded role, Sarah will be responsible for defining and driving the overall product vision and strategy, from ideation to launch and ongoing optimization. Sarah's leadership will ensure the company continues to deliver innovative solutions that create value and meet the evolving needs of its partners. Throughout her 25 years with CorVel, Sarah has been instrumental in the company's success. In her previous role as Vice President of Network Solutions, Sarah playe

    2/13/25 7:25:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Announces Retirement of V. Gordon Clemons

    FORT WORTH, Texas, Nov. 29, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announces V. Gordon Clemons is electing to retire as a member of the Company's Board of Directors (the "Board") and as Chairman of the Board, effective November 26, 2024, after 37 years of service. Clemons founded CorVel Corporation in 1988 and has served as Chairman of the Board since the Company went public in 1991. Effective upon Clemons' retirement, Michael G. Combs, the Company's President and Chief Executive Officer, was appointed as the new Chairman of the Board. Clemons has been an advisor to Combs since 2017, and he will continue to be available to Combs as an outside consultant. "Building CorVe

    11/29/24 1:30:00 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/14/24 6:45:55 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/13/24 5:02:29 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/13/24 4:05:36 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Financials

    Live finance-specific insights

    View All

    CorVel Announces Revenues and Earnings

    FORT WORTH, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter ended June 30, 2025. Revenues for the quarter were $235 million, an increase from $212 million in the June quarter of 2024. Earnings per share for the quarter were $0.52, compared to $0.42 in the same quarter of the prior year.  The earnings per share numbers for the current and prior year have been adjusted to reflect the three-for-one stock split of its common stock which was paid on December 24, 2024. First Quarter Fiscal Year 2026 Highlights  Revenue increased 11% to $235 million, compared to first quarter of fiscal year 2025.Gross profit increased 18% to $5

    8/5/25 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    STAAR Surgical Announces Changes to Board of Directors

    STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company's Board from 2014-2022, as a director, effective April 24, 2025. The Company also announced that Aimee S. Weisner, who has served as a director since 2022, has chosen not to stand for re-election to the Board when her term expires at the Company's 2025 annual meeting of shareholders in June. In addition, the Company announced that Wei Jiang, who has served as a director since 2024, has agreed to

    4/24/25 5:00:00 PM ET
    $AZN
    $CRVL
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Specialty Insurers
    Finance